Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21
Authors
Keywords
-
Journal
Obesity
Volume 22, Issue 3, Pages 705-712
Publisher
Wiley
Online
2013-07-09
DOI
10.1002/oby.20559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation
- (2013) Silvia Bijland et al. CLINICAL SCIENCE
- From fatty liver to fibrosis: A tale of “second hit”
- (2013) Metin Basaranoglu WORLD JOURNAL OF GASTROENTEROLOGY
- Endothelial Progenitor Cell Function Inversely Correlates With Long-term Glucose Control in Diabetic Patients: Association With the Attenuation of the Heme Oxygenase-Adiponectin Axis
- (2012) Yossi Issan et al. CANADIAN JOURNAL OF CARDIOLOGY
- Heme Oxygenase Gene Targeting to Adipocytes Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet
- (2012) Jian Cao et al. HYPERTENSION
- Apo A1 Mimetic Rescues the Diabetic Phenotype of HO-2 Knockout Mice via an Increase in HO-1 Adiponectin and LKBI Signaling Pathway
- (2012) Jian Cao et al. International Journal of Hypertension
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Regulation of Adipogenesis by Natural and Synthetic REV-ERB Ligands
- (2010) Naresh Kumar et al. ENDOCRINOLOGY
- Lentiviral-Human Heme Oxygenase Targeting Endothelium Improved Vascular Function in Angiotensin II Animal Model of Hypertension
- (2010) Jian Cao et al. HUMAN GENE THERAPY
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NAFLD as a Risk Factor for the Development of Diabetes and the Metabolic Syndrome: An Eleven-Year Follow-up Study
- (2009) Leon A Adams et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Heme Oxygenase-1 Protects Against Steatohepatitis in Both Cultured Hepatocytes and Mice
- (2009) Jun Yu et al. GASTROENTEROLOGY
- Negative feedback maintenance of heme homeostasis by its receptor, Rev-erb
- (2009) N. Wu et al. GENES & DEVELOPMENT
- Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats
- (2009) Angelique Nicolai et al. HYPERTENSION
- The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice,
- (2009) Stephen J. Peterson et al. JOURNAL OF LIPID RESEARCH
- PGC-1α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erbα axis
- (2009) Jennifer L. Estall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FGF21 induces PGC-1 and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
- (2009) M. J. Potthoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance
- (2008) M. Li et al. DIABETES
- Pharmacological and Clinical Aspects of Heme Oxygenase
- (2008) N. G. Abraham et al. PHARMACOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started